Oragenics, Inc. (OGEN)
NYSEAMERICAN: OGEN · Real-Time Price · USD
0.290
+0.007 (2.55%)
At close: Feb 21, 2025, 4:00 PM
0.285
-0.005 (-1.72%)
After-hours: Feb 21, 2025, 7:57 PM EST
Oragenics Market Cap
Oragenics has a market cap or net worth of $3.92 million as of February 21, 2025. Its market cap has decreased by -37.83% in one year.
Market Cap
3.92M
Enterprise Value
1.29M
1-Year Change
-37.83%
Ranking
Category
Stock Price
$0.29
Market Cap Chart
Since February 27, 2004, Oragenics's market cap has increased from $900.00K to $3.92M, an increase of 335.21%. That is a compound annual growth rate of 7.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 3.50M | -22.22% |
| Dec 31, 2024 | 4.50M | -68.97% |
| Dec 29, 2023 | 14.50M | 17.89% |
| Dec 30, 2022 | 12.30M | -76.30% |
| Dec 31, 2021 | 51.90M | 89.42% |
| Dec 31, 2020 | 27.40M | 13.69% |
| Dec 31, 2019 | 24.10M | -4.74% |
| Dec 31, 2018 | 25.30M | 118.10% |
| Dec 29, 2017 | 11.60M | -56.23% |
| Dec 30, 2016 | 26.50M | -51.55% |
| Dec 31, 2015 | 54.70M | 69.88% |
| Dec 31, 2014 | 32.20M | -62.43% |
| Dec 31, 2013 | 85.70M | 18.53% |
| Dec 31, 2012 | 72.30M | 1,125.42% |
| Dec 30, 2011 | 5.90M | -65.29% |
| Dec 31, 2010 | 17.00M | -37.73% |
| Dec 31, 2009 | 27.30M | 184.38% |
| Dec 31, 2008 | 9.60M | -16.52% |
| Dec 31, 2007 | 11.50M | -50.00% |
| Dec 29, 2006 | 23.00M | 253.85% |
| Dec 30, 2005 | 6.50M | -88.18% |
| Dec 31, 2004 | 55.00M | 6,011.11% |
View and export this data all the way back to 2004.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.21B |
| UnitedHealth Group | 462.37B |
| Johnson & Johnson | 384.45B |
| Novo Nordisk | 370.84B |
| AbbVie | 354.62B |
| Abbott Laboratories | 230.98B |
| AstraZeneca | 227.07B |
| Merck & Co. | 221.80B |